Back to CVE records
Medium 6.1HealthcarePublished Oct 8, 2020

CVE-2020-24301Users of the HAPI FHIR Testpage Overlay 5.0.0 and below can use a specially crafted URL to exploit an XSS vulnerability in this module, allowing arbitrary JavaScript to be executed in the user's brow…

Updated under an hour ago ()

Does this affect you?

It affects hapifhir testpage_overlay. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.95%, higher than 60% of scored CVEs.

Users of the HAPI FHIR Testpage Overlay 5.0.0 and below can use a specially crafted URL to exploit an XSS vulnerability in this module, allowing arbitrary JavaScript to be executed in the user's browser. The impact of this vulnerability is believed to be low, as this module is intended for testing and not believed to be widely used for any production purposes.

CVSS
6.1 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE)
Not given
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.95% (percentile 60)
Assigned by
mitre
NVD analysis
Modified
Record last updated
Aug 4, 2024
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
hapifhir testpage_overlay
hapifhir:testpage_overlay
through 5.0.0
NVD

References

  • x-refsource-misc, exploit, third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.